Name : VHL/HRCA1 Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN9053455049
| Long name | VHL/HRCA1 Primary Polyclonal Antibody |
| Also known as | VHL/HRCA1 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | VHL/HRCA1 |
| Specificity | This is a highly specific antibody against VHL/HRCA1 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human VHL |
| Gene ID number | 7428 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | A germline mutation of this gene is the basis of familial inheritance of VHL syndrome, Alternatively spliced transcript variants encoding distinct isoforms have been observed, RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein, The protein encoded by this gene is a component of the protein complex that includes elongin B, This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), [provided by RefSeq], and cullin-2, and possesses ubiquitin ligase E3 activity, elongin C, which is a transcription factor that plays a central role in the regulation of gene expression by oxygen, Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | Elongin binding protein, G7 protein, HRCA1, Hippel-Lindau disease tumor suppressor VHL, Protein G7, RCA1, VHL, VHL 1, VHL1, VHLH, VHL_HUMAN, Von Hippel Lindau disease tumor suppressor, Von Hippel-Lindau disease tumor suppressor, pVHL, von Hippel Lindau syndrome, von Hippel Lindau tumor suppressor, von Hippel-Lindau disease tumor suppressor isoform 2, von Hippel-Lindau syndrome protein homolog, von Hippel-Lindau tumor suppressor isoform 1, VHL1, Von Hippel Lindau, pVHL |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | VHL/HRCA1 |
| Short name | VHL/HRCA1 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | E3 ubiquitin protein ligase/HRCA1 (Antibody to), von Hippel-Lindau tumor suppressor |
| Alternative technique | antibodies |
| Alternative to gene target | BT, DNA-templated and biological process this GO :0006508 and proteolysis and biological process this GO :0006950 and response to stress and biological process this GO :0008134 and transcription factor binding and molecular function this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0016020 and membrane and cellular component this GO :0016567 and protein ubiquitination and biological process this GO :0019899 and enzyme binding and molecular function this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0045111 and intermediate filament cytoskeleton and cellular component this GO :0045597 and positive regulation of cell differentiation and biological process this GO :0045893 and positive regulation of transcription, DNA-templated and biological process this GO :0050821 and protein stabilization and biological process this GO :0061418 and regulation of transcription from RNA polymerase II promoter in response to hypoxia and biological process this GO :0061428 and negative regulation of transcription from RNA polymerase II promoter in response to hypoxia and biological process this GO :0071456 and cellular response to hypoxia and biological process, E3 ubiquitin protein ligase, HRCA1 and pVHL and RCA1 and VHL1, VHL and IDBG-17819 and ENSG00000134086 and 7428, Vhl and IDBG-178105 and ENSMUSG00000033933 and 22346, enzyme binding, nuclei, this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0000902 and cell morphogenesis and biological process this GO :0004842 and ubiquitin-protein transferase activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005654 and nucleoplasm and cellular component this GO :0005739 and mitochondrion and cellular component this GO :0005783 and endoplasmic reticulum and cellular component this GO :0005829 and cytosol and cellular component this GO :0006355 and regulation of transcription, this GO :0004842: ubiquitin-protein transferase activity, this GO :0004842: ubiquitin-protein transferase activity and also this GO :0005515: protein binding and also this GO :0008134: transcription factor binding and also this GO :0019899: enzyme binding, this GO :0005515: protein binding, this GO :0008134: transcription factor binding, this GO :0019899: enzyme binding, 79817 and IDBG-644624 and ENSBTAG00000016101 and 540957, von Hippel-Lindau tumor suppressor |
| Identity | 12687 |
| Gene | VHL |
| Long gene name | von Hippel-Lindau tumor suppressor |
| Synonyms gene name | E3 ubiquitin protein ligase , von Hippel-Lindau syndrome von Hippel-Lindau tumor suppressor |
| Synonyms | VHL1 |
| Locus | 3p25, 3 |
| Discovery year | 1986-01-01 |
| GenBank acession | L15409 |
| Entrez gene record | 7428 |
| Pubmed identfication | 9671762 |
| RefSeq identity | NM_000551 |
| Havana BLAST/BLAT | OTTHUMG00000128668 |
| Locus Specific Databases | UMD Locus Specific Databases LRG_322 |